Showing results (491-500 of 546) with videos related to

Sort By:
Pageof 55
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 29, 2022
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductionsFelice Musicco, Ruggero Lasala, Fiorenzo Santoleri, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registriesJohn M Lasala, David A Cox, David Dobies, et al.
European Heart Journal|October 23, 2014
Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessmentJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
JTCVS Open|April 10, 2026
Impact of age at Norwood surgery on pre-stage II outcomes in neonates with hypoplastic left heart syndromeHalil Beqaj, V Reed LaSala, Sophia Jackman, et al.
Circulation. Cardiovascular Interventions|August 6, 2021
Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized StudyDean J Kereiakes, Robert L Feldman, A J J Ijsselmuiden, et al.
Clinical Microbiology Reviews|November 4, 2024
American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysisRobert L Sautter, James Scott Parrott, Irving Nachamkin, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 21, 2018
Observed to expected 30-day mortality as a benchmark for transcatheter aortic valve replacementMatthew C Henn, Alan Zajarias, Nishath Quader, et al.
The Journal of Infectious Diseases|May 24, 2000
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3M H Losso, W H Belloso, S Emery, et al.
Annals of Surgical Oncology|February 12, 2024
Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer CenterJolyn S Taylor, Bryan M Fellman, Sally Raty, et al.
The Review of Scientific Instruments|November 7, 2012
Development of the ITER magnetic diagnostic set and specificationG Vayakis, S Arshad, D Delhom, et al.
Pageof 55